Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1335969

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1335969

Europe Allergy Immunotherapy Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Treatment Type, By Allergy Type, By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Allergy Immunotherapy Market would witness market growth of 7.2% CAGR during the forecast period (2023-2030).

Allergy immunotherapy involves frequent injections that increase the amount to help the patient develop resistance. The patient's immune system becomes less vulnerable as the dosage gradually increases because more blocking antibodies are produced to fight the foreign chemicals that trigger allergies. Because allergic reactions often bring it on and are strongly related to other allergic disorders, asthma is a significant allergy component. As a result, the market is a subsegment of the overall market that is devoted to developing drugs for treating asthma and allergic disorders.

A major trend in the market is a shift toward more individualized and targeted treatment. Growing knowledge exists on the molecular processes that underlie allergic reactions. To satisfy each patient's unique needs, researchers and physicians are creating increasingly sophisticated, customized therapy. The development of biomarkers and diagnostic tools to assist in determining the underlying causes of allergies and directing treatment choices is also driven by this trend.

Most people who live in cities in Europe perform this in areas where the EU's regulations for air quality protection of human health are commonly surpassed. The UK government estimates that 1 to 2% of adults and 5 to 8% of youths in the country suffer from food allergies. Hypersensitivity to food cannot be cured. It necessitates ongoing management. A single action cannot make a consumer's risk disappear. Food allergies will increase because of these factors. Overall, the market is anticipated to expand in this region due to the rise in various allergens.

The Germany market dominated the Europe Allergy Immunotherapy Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $238.5 million by 2030. The UK market is estimated to grow at a CAGR of 6.2% during (2023 - 2030). Additionally, The France market would witness a CAGR of 8% during (2023 - 2030).

Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy. Based on Treatment Type, the market is segmented into Subcutaneous Immunotherapy (SCIT), and Sublingual Immunotherapy (SLIT) (Tablets, and Drops). Based on Allergy Type, the market is segmented into Allergic Rhinitis, Allergic Asthma, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris, Inc. (Mylan N.V.), Merck KGaA, NIOX Group plc, DMS Imaging SA, Adamis Pharmaceuticals Corporation, Stallergenes Greer International AG (B-Flexion), Allergy Therapeutics plc, DBV Technologies S.A., HAL Allergy B.V. (Droege International Group AG.), LETI Pharma, S.L.U.

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

By Treatment Type

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)
    • Tablets
    • Drops

By Allergy Type

  • Allergic Rhinitis
  • Allergic Asthma
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Viatris, Inc. (Mylan N.V.)
  • Merck KGaA
  • NIOX Group plc
  • DMS Imaging SA
  • Adamis Pharmaceuticals Corporation
  • Stallergenes Greer International AG (B-Flexion)
  • Allergy Therapeutics plc
  • DBV Technologies S.A.
  • HAL Allergy B.V. (Droege International Group AG.)
  • LETI Pharma, S.L.U.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Allergy Immunotherapy Market, by Distribution Channel
    • 1.4.2 Europe Allergy Immunotherapy Market, by Treatment Type
    • 1.4.3 Europe Allergy Immunotherapy Market, by Allergy Type
    • 1.4.4 Europe Allergy Immunotherapy Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market At a Glance

  • 2.1 Key Highlight

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Forces Analysis

Chapter 4. Europe Allergy Immunotherapy Market by Distribution Channel

  • 4.1 Europe Retail Pharmacy Market by Country
  • 4.2 Europe Hospital Pharmacy Market by Country
  • 4.3 Europe Online Pharmacy Market by Country

Chapter 5. Europe Allergy Immunotherapy Market by Treatment Type

  • 5.1 Europe Subcutaneous Immunotherapy (SCIT) Market by Country
  • 5.2 Europe Sublingual Immunotherapy (SLIT) Market by Country
  • 5.3 Europe Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 5.3.1 Europe Tablets Market by Country
    • 5.3.2 Europe Drops Market by Country

Chapter 6. Europe Allergy Immunotherapy Market by Allergy Type

  • 6.1 Europe Allergic Rhinitis Market by Country
  • 6.2 Europe Allergic Asthma Market by Country
  • 6.3 Europe Others Market by Country

Chapter 7. Europe Allergy Immunotherapy Market by Country

  • 7.1 Germany Allergy Immunotherapy Market
    • 7.1.1 Germany Allergy Immunotherapy Market by Distribution Channel
    • 7.1.2 Germany Allergy Immunotherapy Market by Treatment Type
      • 7.1.2.1 Germany Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 7.1.3 Germany Allergy Immunotherapy Market by Allergy Type
  • 7.2 UK Allergy Immunotherapy Market
    • 7.2.1 UK Allergy Immunotherapy Market by Distribution Channel
    • 7.2.2 UK Allergy Immunotherapy Market by Treatment Type
      • 7.2.2.1 UK Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 7.2.3 UK Allergy Immunotherapy Market by Allergy Type
  • 7.3 France Allergy Immunotherapy Market
    • 7.3.1 France Allergy Immunotherapy Market by Distribution Channel
    • 7.3.2 France Allergy Immunotherapy Market by Treatment Type
      • 7.3.2.1 France Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 7.3.3 France Allergy Immunotherapy Market by Allergy Type
  • 7.4 Russia Allergy Immunotherapy Market
    • 7.4.1 Russia Allergy Immunotherapy Market by Distribution Channel
    • 7.4.2 Russia Allergy Immunotherapy Market by Treatment Type
      • 7.4.2.1 Russia Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 7.4.3 Russia Allergy Immunotherapy Market by Allergy Type
  • 7.5 Spain Allergy Immunotherapy Market
    • 7.5.1 Spain Allergy Immunotherapy Market by Distribution Channel
    • 7.5.2 Spain Allergy Immunotherapy Market by Treatment Type
      • 7.5.2.1 Spain Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 7.5.3 Spain Allergy Immunotherapy Market by Allergy Type
  • 7.6 Italy Allergy Immunotherapy Market
    • 7.6.1 Italy Allergy Immunotherapy Market by Distribution Channel
    • 7.6.2 Italy Allergy Immunotherapy Market by Treatment Type
      • 7.6.2.1 Italy Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 7.6.3 Italy Allergy Immunotherapy Market by Allergy Type
  • 7.7 Rest of Europe Allergy Immunotherapy Market
    • 7.7.1 Rest of Europe Allergy Immunotherapy Market by Distribution Channel
    • 7.7.2 Rest of Europe Allergy Immunotherapy Market by Treatment Type
      • 7.7.2.1 Rest of Europe Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type
    • 7.7.3 Rest of Europe Allergy Immunotherapy Market by Allergy Type

Chapter 8. Company Profiles

  • 8.1 Viatris, Inc. (Mylan N.V.)
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 SWOT Analysis
  • 8.2 Merck KGaA
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 SWOT Analysis
  • 8.3 NIOX Group plc
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental Analysis
    • 8.3.4 Research & Development Expenses
    • 8.3.5 SWOT Analysis
  • 8.4 DMS Imaging SA
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Regional Analysis
    • 8.4.4 SWOT Analysis
  • 8.5 Adamis Pharmaceuticals Corporation
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Research & Development Expenses
    • 8.5.4 SWOT Analysis
  • 8.6 Stallergenes Greer International AG (B-Flexion)
    • 8.6.1 Company Overview
    • 8.6.2 Recent strategies and developments:
      • 8.6.2.1 Partnerships, Collaborations, and Agreements:
      • 8.6.2.2 Acquisition and Mergers:
    • 8.6.3 SWOT Analysis
  • 8.7 Allergy Therapeutics plc
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental Analysis
    • 8.7.4 Research & Development Expenses
    • 8.7.5 SWOT Analysis
  • 8.8 DBV Technologies S.A.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Research & Development Expenses
    • 8.8.4 SWOT Analysis
  • 8.9 HAL Allergy B.V. (Droege International Group AG.)
    • 8.9.1 Company Overview
    • 8.9.2 SWOT Analysis
  • 8.10. LETI Pharma, S.L.U.
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Europe Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 2 Europe Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 3 Europe Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 4 Europe Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 5 Europe Retail Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 6 Europe Retail Pharmacy Market by Country, 2023 - 2030, USD Million
  • TABLE 7 Europe Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 8 Europe Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
  • TABLE 9 Europe Online Pharmacy Market by Country, 2019 - 2022, USD Million
  • TABLE 10 Europe Online Pharmacy Market by Country, 2023 - 2030, USD Million
  • TABLE 11 Europe Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 12 Europe Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 13 Europe Subcutaneous Immunotherapy (SCIT) Market by Country, 2019 - 2022, USD Million
  • TABLE 14 Europe Subcutaneous Immunotherapy (SCIT) Market by Country, 2023 - 2030, USD Million
  • TABLE 15 Europe Sublingual Immunotherapy (SLIT) Market by Country, 2019 - 2022, USD Million
  • TABLE 16 Europe Sublingual Immunotherapy (SLIT) Market by Country, 2023 - 2030, USD Million
  • TABLE 17 Europe Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 18 Europe Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 19 Europe Tablets Market by Country, 2019 - 2022, USD Million
  • TABLE 20 Europe Tablets Market by Country, 2023 - 2030, USD Million
  • TABLE 21 Europe Drops Market by Country, 2019 - 2022, USD Million
  • TABLE 22 Europe Drops Market by Country, 2023 - 2030, USD Million
  • TABLE 23 Europe Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 24 Europe Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 25 Europe Allergic Rhinitis Market by Country, 2019 - 2022, USD Million
  • TABLE 26 Europe Allergic Rhinitis Market by Country, 2023 - 2030, USD Million
  • TABLE 27 Europe Allergic Asthma Market by Country, 2019 - 2022, USD Million
  • TABLE 28 Europe Allergic Asthma Market by Country, 2023 - 2030, USD Million
  • TABLE 29 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 30 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 31 Europe Allergy Immunotherapy Market by Country, 2019 - 2022, USD Million
  • TABLE 32 Europe Allergy Immunotherapy Market by Country, 2023 - 2030, USD Million
  • TABLE 33 Germany Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 34 Germany Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 35 Germany Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 36 Germany Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 37 Germany Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 38 Germany Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 39 Germany Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 40 Germany Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 41 Germany Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 42 Germany Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 43 UK Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 44 UK Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 45 UK Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 46 UK Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 47 UK Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 48 UK Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 49 UK Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 50 UK Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 51 UK Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 52 UK Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 53 France Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 54 France Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 55 France Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 56 France Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 57 France Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 58 France Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 59 France Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 60 France Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 61 France Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 62 France Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 63 Russia Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 64 Russia Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 65 Russia Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 66 Russia Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 67 Russia Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 68 Russia Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 69 Russia Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 70 Russia Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 71 Russia Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 72 Russia Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 73 Spain Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 74 Spain Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 75 Spain Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 76 Spain Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 77 Spain Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 78 Spain Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 79 Spain Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 80 Spain Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 81 Spain Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 82 Spain Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 83 Italy Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 84 Italy Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 85 Italy Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 86 Italy Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 87 Italy Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 88 Italy Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 89 Italy Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 90 Italy Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 91 Italy Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 92 Italy Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 93 Rest of Europe Allergy Immunotherapy Market, 2019 - 2022, USD Million
  • TABLE 94 Rest of Europe Allergy Immunotherapy Market, 2023 - 2030, USD Million
  • TABLE 95 Rest of Europe Allergy Immunotherapy Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 96 Rest of Europe Allergy Immunotherapy Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 97 Rest of Europe Allergy Immunotherapy Market by Treatment Type, 2019 - 2022, USD Million
  • TABLE 98 Rest of Europe Allergy Immunotherapy Market by Treatment Type, 2023 - 2030, USD Million
  • TABLE 99 Rest of Europe Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2019 - 2022, USD Million
  • TABLE 100 Rest of Europe Allergy Immunotherapy Market by Sublingual Immunotherapy (SLIT) Type, 2023 - 2030, USD Million
  • TABLE 101 Rest of Europe Allergy Immunotherapy Market by Allergy Type, 2019 - 2022, USD Million
  • TABLE 102 Rest of Europe Allergy Immunotherapy Market by Allergy Type, 2023 - 2030, USD Million
  • TABLE 103 key information - Viatris, Inc.
  • TABLE 104 key Information - Merck KGaA
  • TABLE 105 Key Information - NIOX Group plc
  • TABLE 106 Key Information - DMS Imaging SA
  • TABLE 107 Key Information - Adamis Pharmaceuticals Corporation
  • TABLE 108 Key Information - Stallergenes Greer International AG
  • TABLE 109 Key Information - Allergy Therapeutics plc
  • TABLE 110 Key Information - DBV TECHNOLOGIES S.A.
  • TABLE 111 Key Information - HAL Allergy B.V.
  • TABLE 112 Key Information - LETI Pharma, S.L.U.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Europe Allergy Immunotherapy Market, 2019 - 2030, USD Million
  • FIG 3 Key Factors Impacting the Allergy Immunotherapy Market
  • FIG 4 Porter's Five Forces Analysis - Allergy Immunotherapy Market
  • FIG 5 Europe Allergy Immunotherapy Market share by Distribution Channel, 2022
  • FIG 6 Europe Allergy Immunotherapy Market share by Distribution Channel, 2030
  • FIG 7 Europe Allergy Immunotherapy Market by Distribution Channel, 2019 - 2030, USD Million
  • FIG 8 Europe Allergy Immunotherapy Market share by Treatment Type, 2022
  • FIG 9 Europe Allergy Immunotherapy Market share by Treatment Type, 2030
  • FIG 10 Europe Allergy Immunotherapy Market by Treatment Type, 2019 - 2030, USD Million
  • FIG 11 Europe Allergy Immunotherapy Market share by Allergy Type, 2022
  • FIG 12 Europe Allergy Immunotherapy Market share by Allergy Type, 2030
  • FIG 13 Europe Allergy Immunotherapy Market by Allergy Type, 2019 - 2030, USD Million
  • FIG 14 Europe Allergy Immunotherapy Market share by Country, 2022
  • FIG 15 Europe Allergy Immunotherapy Market share by Country, 2030
  • FIG 16 Europe Allergy Immunotherapy Market by Country, 2019 - 2030, USD Million
  • FIG 17 SWOT Analysis: Viatris, Inc.
  • FIG 18 Swot Analysis: Merck KGaA
  • FIG 19 SWOT Analysis: NIOX Group plc
  • FIG 20 SWOT Analysis: DMS Imaging SA
  • FIG 21 SWOT Analysis: Adamis Pharmaceuticals Corporation
  • FIG 22 Recent strategies and developments: Stallergenes Greer International AG
  • FIG 23 SWOT Analysis: Stallergenes Greer International AG
  • FIG 24 SWOT Analysis: Allergy Therapeutics plc
  • FIG 25 SWOT Analysis: DBV Technologies S.A.
  • FIG 26 SWOT Analysis: HAL Allergy B.V.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!